Drawing for SMART

USPTO serial 76469610

SMART

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BELLO, ZACK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SMART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William P. Nix

ROCHELLE K SEIDE ARENT FOX PLLC1675 BROADWAYNEW YORK, NY 10019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in the science and technology industry, namely precursors for in vitro genetic engineering use namely biochemicals used for treating medical disorders and diseases; those used for creating genetically or engineered plants; those used for agricultural crops; those used as diagnostic preparations or reagents for scientific or research use; those used as plant growth regulators for agricultural use; reagents for scientific or medical research useACTIVE—
005Pharmaceuticals, namely preparations for medical uses including for the treatment of genetic diseases, cancer, infections with pathogenic organisms; reagents for medical diagnostics; vaccines for the treatment of both animal and human diseases including bacterial and viral diseasesACTIVE—
009Scientific apparatus articles and kits for research in laboratories namely biotechnology related research and genetic engineering researchACTIVE—
010Medical apparatus articles and kits for diagnosing pathological or genetic disordersACTIVE—
031Agricultural, horticultural, forestry products and grains namely genetically engineered plants, living animals, namely transgenic animalsACTIVE—
040Treatment of materials rendered by mechanical or chemical processing or the transformation of objects, organic or inorganic marked by the applicant, who made such transformations or processing namelyACTIVE—
042Providing services namely medical care, diagnostics and prognostics and agricultural services and scientific and industrial research namely research on genomesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 11, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 5, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance